AzTrials
AzTrials

ComaNCT02338284

Optic Nerve Sheath Diameter as a Screening Test for Increased Intracranial Pressure

An observational study of Coma, run by King Faisal Specialist Hospital & Research Center at 1 site in Saudi Arabia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients admitted to the ICU may have delayed awakening after their critical illness has resolved. Though most either are due to metabolic causes or delayed elimination of sedative medications, more serious pathologies such as intracranial hemorrhage, ischemic stroke, and vasogenic edema may also be the cause of coma. Read more about this study

Who is it for?
Ages 14 years and older
Conditions the study is for
Coma
What is being tested?
ultrasound of globe
How many people
100 participants
Where
1 siteSaudi Arabia
Study dates
Oct 2014to Sep 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Consecutive, adult patients already admitted to the critical care service with unexplained coma

Who may be able to join

  • Consecutive, adult patients already admitted to the critical care service and in whom a cause of coma is not determined.

Who cannot join

  • Obvious ocular trauma
  • Patients on sedative or narcotic infusions

Trial locations and contacts

1 site in 1 country.

Alaa Mohamed, MD contact

966553730044

dr.alaibrahim@gmail.com

NADIA ALHARBI, MD contact

966562042098

dr-n.al-harbi@yahoo.com

Saudi Arabia1 site, 1 recruiting
  • King Faisal Specialist Hospital & Research Centre

    Riyadh, Ar-Riyadh, 11211

    Alaa Mohamed, MD, 966553730044, dr.alaibrahim@gmail.com

    nawal salahuddin, MD,FCCP, 966551948786, nsalahuddin@kfshrc.edu.sa

    Recruiting

Other trials in Saudi Arabia

About this study

Official title: Optic Nerve Sheath Diameter Measured by Bedside Ultrasound May be a Simple Screening Test for Increased Intracranial Pressure in the Comatose Critically Ill Patient

Patients admitted to the ICU may have delayed awakening after their critical illness has resolved. Though most either are due to metabolic causes or delayed elimination of sedative medications, more serious pathologies such as intracranial hemorrhage, ischemic stroke, and vasogenic edema may also be the cause of coma. These pathologies all result in increases in intracranial pressure (ICP) with cerebral edema. Identifying elevated intracranial pressure elevations have so far, relied on invasive monitoring techniques requiring placement of an intracranial or intraventricular catheter.

The optic nerve sheath diameter (ONSD) has been described as a highly sensitive (88-94%) and specific (85% - 94%) noninvasive technique of identifying increased intracranial pressures in patients with brain trauma, intracranial bleeding or stroke[1-4]. This method requires placement of an ultrasound probe on the patient's closed eyelid and then a direct measurement of the diameter of the optic nerve sheath at a pre-specified distance from the globe. A value greater than 58 mm has been shown to correlate significantly with an increased ICP (> 20 cm H20); r = 0.71, p<0.001 [5].

The investigators hypothesize that bedside ultrasound measurement of the ONSD is a simple screening test for increased intracranial pressure and can be used to rapidly and efficiently identify patients in the ICU who have coma due to an increase in intracranial pressure. The investigators propose to carry out an observational trial to determine the predictive ability of the Optic Nerve Sheath Diameter for cerebral edema/ increased intracranial pressure and to compare it with the results of neuroimaging (CT and/or MRI).

Read the detailed description

Patients admitted to the ICU may have delayed awakening after their critical illness has resolved. Though most either are due to metabolic causes or delayed elimination of sedative medications, more serious pathologies such as intracranial hemorrhage, ischemic stroke, and vasogenic edema may also be the cause of coma. These pathologies all result in increases in intracranial pressure (ICP) with cerebral edema. At this stage, the usual workup includes brain CT scans, MRI or EEG. These tests require transporting the patient from the ICU to the Radiology department, a process that may not be possible for an unstable, critically ill patient. Identifying elevated intracranial pressure elevations have so far, relied on invasive monitoring techniques requiring placement of an intracranial or intraventricular catheter.

The optic nerve attaches to the globe posteriorly and is wrapped in a sheath that contains cerebrospinal fluid. The optic nerve sheath is contiguous with the dura mater and has a trabeculated arachnoid space through which cerebrospinal fluid slowly percolates. Pressure increases around the brain are therefore transmitted to around the optic nerve and increase the diameter of the optic nerve sheath. This optic nerve sheath diameter (ONSD) has been described as a highly sensitive (88-94%) and specific (85% - 94%) noninvasive technique of identifying increased intracranial pressures in patients with brain trauma, intracranial bleeding or stroke[1-4]. This method requires placement of an ultrasound probe on the patient's closed eyelid and then a direct measurement of the diameter of the optic nerve sheath at a pre-specified distance from the globe. A value greater than 58 mm has been shown to correlate significantly with an increased ICP (> 20 cm H20); r = 0.71, p<0.001 [5].

We hypothesize that bedside ultrasound measurement of the ONSD is a simple screening test for increased intracranial pressure and can be used to rapidly and efficiently identify patients in the ICU who have coma due to an increase in intracranial pressure.

Objectives:

To determine the role of bedside ONSD measurement by ultrasound in the evaluation of comatose patients in the ICU.

METHODS:

  • Study Design: Prospective, Observational study
  • Study Sample:
  • Inclusion criteria: Consecutive, adult patients already admitted to the critical care service and in whom a cause of coma is not determined.
  • Exclusion criteria: obvious ocular trauma, patients on sedative or narcotic infusions.

Variables to be measured:

Independent variables:

Demographic identifiers; age, gender, comorbidity, admitting diagnosis, APACHE II scores, SAPS II scores

Dependent (Outcome) variables:

  1. Diagnosis of cerebral edema/ elevated intracranial pressure as measured by Optic nerve sheath diameter
  2. Diagnosis of cerebral edema/ elevated intracranial pressure as measured by neuroimaging
  3. ICU mortality

Materials \& Methodologies:

  1. Screening \& Enrollment of patients:
  2. All ICU patients will be screened for enrollment.
  3. For patients meeting the inclusion criteria, informed consent will be obtained from the patient or family members at bedside.
  4. Demographic information will be collected in Case Record Forms (Appendix 2: Sample CRF)
  5. Ultrasound examinations will be carried out and results entered into a CRF.
  6. Technique of ONSD ultrasound measurement from Reference 6.
  • A high resolution 7.5 -10 MHz linear array ultrasound transducer probe will be used. A large amount of standard water-soluble ultrasound transmission gel will be applied to the patient's closed eyelid. The globe will be scanned in the transverse plane.
  • The ONSD will be measured at a predefined point 3 mm posterior to the globe in both eyes.
  • Measurement of the ONSD for both eyes will be done and the average the two measurements will be taken.
  • A value > 58mm (from reference 1) will be considered as indicative of increased ICP and the primary ICU team will be informed for rapid measures to decrease ICP or urgent imaging of the CNS.
  1. Statistical Methods:
  2. Sample size \& Sampling: Consecutive admissions to the ICU will be enrolled. Since this is a proof of concept study, the projected sample size is 40 patients. An interim analysis will be carried out after 20 patients are enrolled and a further 20 will be enrolled as necessary
  3. Analysis: Categorical variables will be reported as proportions or percentages, continuous variables as means or medians. Differences between groups will be estimated using CHI2, student t test or Mann-Whitney U test, as appropriate. A p value =0.05 will be considered significant. SPSS version 22.0 will be used for all analysis.

Ethical considerations:

  • Informed Consent for ultrasonographic examination. The use of use of ultrasound for the assessment and management of critically ill patients in the ICU and emergency room is considered as standard of care and is routinely practiced in ICUs around the world. Since ultrasound evaluation has become incorporated into usual ICU practice, written consent is not required in its routine use. We therefore ask for a waiver of informed consent since we will not be performing any deviation from usual ICU care and our study is simply a collection of practice into a protocolized form.
  • Research Advisory Committee (RAC) Review This protocol will be reviewed and approved by the hospital Research Advisory committee responsible for oversight of the study.
  1. Subject Confidentiality \& Protection of Rights of Control Subjects All case record forms, reports and other records will be identified only by the Study Identification Number (SID) to maintain subject confidentiality. All records will be kept in a password-protected file. All computer entry and networking programs will be done using SIDs only.
  2. Study Modification/Discontinuation The study may be modified or discontinued at any time by the primary investigators and or Research Advisory Committee as part of their duties to ensure that research subjects are protected.
Conditions
Coma
Being tested
ultrasound of globe
Keywords
increased intracranial pressure, optic nerve sheath diameter
Medical subject headings
Coma, Intracranial Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasound of globeOther

    • A high resolution 7.5 -10 MHz linear array ultrasound transducer probe will be used. A large amount of standard water-soluble ultrasound transmission gel will be applied to the patient's closed eyelid. The globe will be scanned in the transverse plane.• The ONSD will be measured at a predefined point 3 mm posterior to the globe in both eyes. • Measurement of the ONSD for both eyes will be done and the average the two measurements will be taken.
    • A value > 58mm (from reference 1) will be considered as indicative of increased ICP and the primary ICU team will be informed for rapid measures to decrease ICP or urgent imaging of the CNS.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnosis of Cerebral edema by Optic nerve sheath diameter

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2015 (estimated)
  2. Study startOct 2014
  3. Primary completionSep 2015 (estimated)
  4. Study completionSep 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02338284
Sponsor's protocol ID
2141 103
Status last verified
Jun 2015
First submitted
6 Jan 2015
Last updated
16 Jun 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Coma, run by King Faisal Specialist Hospital & Research Center at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alaa Mohamed, MD (966553730044, dr.alaibrahim@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnosis of Cerebral edema by Optic nerve sheath diameter (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2015.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in